Fig. 3 | Scientific Reports

Fig. 3

From: Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)

Fig. 3

Progression-free survival analysis. Progression-free survival analysis of patients with pancreatic cancer using different neutropenia grade cutoffs (A: cutoff A, B: cutoff B, and C: cutoff C). The graph displays the survival curves and corresponding hazard ratios for each cutoff group. Cutoffs A and B show significant differences. Cutoff C also shows a trend toward improved survival, although the difference is not statistically significant.

Back to article page